Document is current
Any future updates will be listed below
-
Authors
Rouzé, Anahita
Lemaitre, Elise
Martin-Loeches, Ignacio
Povoa, Pedro
Diaz, Emili
Nyga, Rémy
Torres, Antoni
Metzelard, Matthieu
Du Cheyron, Damien
Lambiotte, Fabien
Tamion, Fabienne
Labruyere, Marie
Boulle Geronimi, Claire
Luyt, Charles-Edouard
Nyunga, Martine
Pouly, Olivier
Thille, Arnaud W.
Megarbane, Bruno
Saade, Anastasia
Magira, Eleni
Llitjos, Jean-François
Ioannidou, Iliana
Pierre, Alexandre
Reignier, Jean
Garot, Denis
Kreitmann, Louis
Baudel, Jean-Luc
Voiriot, Guillaume
Plantefeve, Gaëtan
Morawiec, Elise
Asfar, Pierre
Boyer, Alexandre
Mekontso-Dessap, Armand
Makris, Demosthenes
Vinsonneau, Christophe
Floch, Pierre-Edouard
Marois, Clémence
Ceccato, Adrian
Artigas, Antonio
Gaudet, Alexandre
Nora, David
Cornu, Marjorie
Duhamel, Alain
Labreuche, Julien
Nseir, Saad http://orcid.org/0000-0002-7618-0357
,
Bouchereau, Mathilde
Sendid, Boualem
Boyd, Sean
Coelho, Luis
Maizel, Julien
Cuchet, Pierre
Zarrougui, Wafa
Boyer, Déborah
Quenot, Jean-Pierre
Imouloudene, Mehdi
de Chambrun, Marc Pineton
Van Der Linden, Thierry
Arrive, François
Voicu, Sebastian
Azoulay, Elie
Moglia, Edgard
Pene, Frédéric
Cilloniz, Catia
Thevenin, Didier
Larrat, Charlotte
Argaud, Laurent
Guidet, Bertrand
Turpin, Matthieu
Contou, Damien
Beurton, Alexandra
Demiselle, Julien
Meguerditchian, David
Razazi, Keyvan
Arrestier, Romain
Tsolaki, Vassiliki
Marzouk, Mehdi
Brunin, Guillaume
Weiss, Nicolas
Morales, Luis
- License Information
-
More Information
Article History
Received: 22 October 2021
Accepted: 17 December 2021
First Online: 4 January 2022
Declarations
:
: The Ethics Committee and Institutional Review Boards approved the study protocol (Comité de Protection des Personnes Ouest VI; approved by April 14, 2020; registration number RIPH:20.04.09.60039) as minimal-risk research using data collected for routine clinical practice and waived the requirement for informed consent.
: Not applicable.
: AR received personal fees from Maat Pharma, IML received personal fees from MSD, and Gilead. AA received personal fees from Lilly Foundation, and grants from Grifols and Fisher & Paykel. CEL received personal fees from Bayer, Merck, Aerogen, Biomérieux, ThermoFisher Brahms, and Carmat. SN received personal fees from MSD, Bio-Rad, BioMérieux, Gilead, Fisher and Paykel, and Pfizer. All other authors declare no competing interests.
